Skip to content
OpenCapital
Get started

Aclaris Therapeutics ACRS Available For Sale Securities Debt Securities Current

Available For Sale Securities Debt Securities Current at other companies

Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
——
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
——
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
——
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
——
Arcus Biosciences logo
Arcus BiosciencesRCUS
——
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
——

Other financials

Income statement

See full
Revenue$2.0M+37.2%
Gross profit$1.6M+68.7%
Operating income-$22.2M-22.7%
Net income-$19.8M-31.4%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$28.7M-5.6%
Total debt$2.0M-20.1%
Total equity$143.6M-0.3%
Total assets$198.7M+0.3%

Cash flow

See full
Operating cash flow-$18.1M-39.0%
CapEx$13.0K-69.8%
Free cash flow-$18.2M-38.6%

Valuation

See full
Market cap$685.75M+337%
Enterprise value$659.07M+410%
P/S82×+73.1×

Profitability

See full
Gross margin76.3%-9.7pp
Operating margin-961.9%+259pp
Net margin-832.6%+132pp
FCF margin-624.9%—

Returns & leverage

See full
Return on equity-48.4%-15.4pp
Debt / equity0×0.0×
Current ratio4×-1.0×

Where this comes from

Reported directly by Aclaris Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's available for sale securities debt securities current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aclaris Therapeutics's available for sale securities debt securities current?
Aclaris Therapeutics (ACRS) reported available for sale securities debt securities current of $76.76M in Q1 2026.
How has Aclaris Therapeutics's available for sale securities debt securities current changed year-over-year?
Aclaris Therapeutics's available for sale securities debt securities current increased by 2.4% year-over-year, from $74.96M to $76.76M.
What is the long-term trend for Aclaris Therapeutics's available for sale securities debt securities current?
Over 5 years (2020 to 2025), Aclaris Therapeutics's available for sale securities debt securities current has grown at a 17.2% compound annual growth rate (CAGR), from $32.07M to $70.79M.